[O5] Oral Presentations 5

3:00 PM - 3:10 PM JST(6:00 AM - 6:10 AM UTC)R&D IIIVaccine ScienceCandidate for the Oral Presentation Award for Early-career Researchers

[O5-01E] Pathogen specific mucosal and systemic immunity is induced by sublingual delivery of inactivated enterovirus 71

*Risa Takahashi^1,2, Meito Shibuya^1,2,3, Tomoyuki Yamanoue^1,2, Tomonori Machita^1,2, Fujimi Arai^1,2, Satomi Takahashi^1,2, Hiroshi Kiyono^1,2,4,5,6,7, Kohtaro Fujihashi^1,2,7,8,9 (1. Department of Human Mucosal Vaccinology, Chiba University Hospital (Japan), 2. Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), Chiba University (Japan), 3. Vaccine R&D Laboratory, Vaccine Business Division, Shionogi & Co., Ltd (Japan), 4. Future Medicine Education and Research Organization, Chiba University (Japan), 5. Department of Medicine, UC San Diego School of Medicine, San Diego (USA), 6. CU-UCSD Center for Mucosal Immunology, Allergy and Vaccines (cMAV), UC San Diego School of Medicine (USA), 7. Division of Infectious Disease Vaccine R&D, Research Institute of Disaster Medicine, Chiba University (Japan), 8. Division of Mucosal Vaccines, International Vaccince Design Center, The Institute of Medical Science, The University of Tokyo (Japan), 9. Department of Pediatric Dentistry, The University of Alabama at Birmingham (USA))

Password required to view

Log in

or